Vanna Gold
Family Medicine · Lampasas, TXNPI 1669818910
Payments from drug & device makers
Across 1,250 payments — averaging $2659.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Applied Therapeutics, Inc.$900K
- AbbVie$416K
- GSK$340K
- Sanofi US Services Inc.$314K
- Merck$310K
- Genentech, Inc.$210K
- plus $835K from 29 others
Across 6 payments — averaging $3082.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$18K
- Sanofi US Services Inc.$40
What the payments were for
- Food & beverage$1,527100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Applied Therapeutics, Inc. | 110 | $899,769 |
| AbbVie(2 entities) | 191 | $415,755 |
| GSK | 172 | $340,045 |
| Sanofi US Services Inc. | 104 | $313,526 |
| Merck | 19 | $310,312 |
| Genentech, Inc. | 46 | $209,729 |
| Exeltis, USA Inc. | 57 | $187,411 |
| AstraZeneca | 25 | $152,421 |
| Novartis | 7 | $121,298 |
| Sanofi Pasteur Inc. | 36 | $105,329 |
| Ionis Pharmaceuticals, Inc. | 28 | $97,267 |
| Biohaven Pharmaceutical Holding Company Ltd. | 25 | $79,883 |
| Novo Nordisk AS | 347 | $47,483 |
| Pfizer | 9 | $17,983 |
| Supernus Pharmaceuticals, Inc. | 8 | $10,683 |
| Chiesi USA, Inc. | 1 | $9,500 |
| Amgen | 7 | $4,659 |
| Novo Nordisk | 20 | $247 |
| Biohaven Pharmaceuticals, Inc. | 6 | $167 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $69 |
| Amarin Pharma, Inc. | 3 | $63 |
| Boehringer Ingelheim | 3 | $51 |
| Sanofi-aventis U.S. LLC | 3 | $45 |
| Lilly USA, LLC | 3 | $36 |
| Eisai Inc. | 2 | $31 |
| Cranial Technologies, Inc | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $27 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Mission Pharmacal Company | 1 | $15 |
| Biogen | 1 | $14 |
| Astellas Pharma US Inc | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
| Circassia Inc. | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
How this compares
$3,323,927 in reported general payments places this provider in the 95th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 31 | $10,593 |
| Mirtazapine | 23 | $1,469 |
| Amiodarone Hcl | 15 | $1,233 |
| Losartan Potassium | 55 | $1,166 |
| Duloxetine Hcl | 35 | $1,124 |
| Metoprolol Succinate | 28 | $630 |
| Levothyroxine Sodium | 42 | $621 |
| Gabapentin | 35 | $394 |
| Atorvastatin Calcium | 45 | $379 |
| Famotidine | 42 | $307 |
| Buspirone Hcl | 16 | $267 |
| Amoxicillin | 12 | $249 |
| Latanoprost | 15 | $214 |
| Ondansetron Hcl | 19 | $210 |
| Furosemide | 18 | $208 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $17,983 | $10,59331 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Lampasas
- James CainLampasas$2.9M
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.